Composition
- Active ingredients
- VUTRISIRAN SODIUM EQ 25MG BASE/0.5ML (EQ 25MG BASE/0.5ML)
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA215515.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Amvuttra
- Active substance
- vutrisiran sodium
- Route
- Subcutaneous
- Dosage form
- Solution
- Applicant
- Alnylam Pharms Inc
- Status
- Prescription
- FDA approval
- 13 Jun 2022
- Application
- NDA215515-001